Peptides Derived from the Tight Junction Protein CLDN1 Disrupt the Skin Barrier and Promote Responsiveness to an Epicutaneous VaccineMatthew G. Brewer, Benjamin L. Miller, Radha P. Pandya et al.|Journal of Investigative Dermatology|2019Cited by 21